Novel cancer vaccine based on genes of Salmonella pathogenicity island 2.

Faculty Pharmacy Year: 2010
Type of Publication: ZU Hosted Pages: 2622–2634
Authors:
Mohammed Ibrahim Huseni
Journal: International Journal of Cancer UICC Volume: 11
Keywords : Novel cancer vaccine based , genes , Salmonella    
Abstract:
Although tumors express potentially immunogenic tumor-associated antigens (TAAs), cancer vaccines often fail because of inadequate antigen delivery and/or insufficient activation of innate immunity. Engineering nonpathogenic bacterial vecto
    
     
 
       

Author Related Publications

  • Mohammed Ibrahim Huseni, "Avian influenza: virology, diagnosis and surveillance", Future Medicine, 2013 More
  • Mohammed Ibrahim Huseni, "Endogenous IFNγ in chronic HCV genotype 4 patients treated with PEG-IFNα and ribavirin", JIDC, 2013 More
  • Mohammed Ibrahim Huseni, "Hydrazones of 2-aryl-quinoline-4-carboxylic acid hydrazides: synthesis and preliminary evaluation as antimicrobial agents", ELSEVIER, 2006 More
  • Mohammed Ibrahim Huseni, "Recombinant vaccines based on translocated effector proteins of Salmonella Pathogenicity Island 2.", ELSEVIER, 2007 More
  • Mohammed Ibrahim Huseni, "Biosynthesis of gold nanoparticles using Pseudomonas aeruginosa.", ELSEVIER, 2007 More

Department Related Publications

  • Mo'men Mahmoud Ezzelarab Abdelaziz Metwally Askoura, "Phenotypic, molecular, and in silico characterization of coumarin as carbapenemase inhibitor to fight carbapenem-resistant Klebsiella pneumoniae", Springer Nature, 2024 More
  • Galal Yehya Abdelreheem Metwally, "Phenotypic, molecular, and in silico characterization of coumarin as carbapenemase inhibitor to fight carbapenem-resistant Klebsiella pneumoniae", Springer Nature, 2024 More
  • Amira Mohamed Mohamed Ali Elganayny, "Phenotypic, molecular, and in silico characterization of coumarin as carbapenemase inhibitor to fight carbapenem-resistant Klebsiella pneumoniae", Springer Nature, 2024 More
  • Hemmat Kamal Abdelattef Ibrahiem, "Phenotypic, molecular, and in silico characterization of coumarin as carbapenemase inhibitor to fight carbapenem-resistant Klebsiella pneumoniae", Springer Nature, 2024 More
Tweet